Necitumumab

Necitumumab (proposed INN) is a recombinant human IgG1 monoclonal antibody used as an antineoplastic. It binds to the epidermal growth factor receptor (EGFR). The US FDA approved necitumumab under the brand name Portrazza for use with gemcitabine and cisplatin in previously untreated metastatic squamous non-small-cell lung carcinoma (NSCLC). It was counterproductive in non-squamous non-small-cell lung carcinoma.

单词	Necitumumab
释义	Necitumumab 英语百科 Necitumumab Necitumumab (proposed INN) is a recombinant human IgG1 monoclonal antibody used as an antineoplastic. It binds to the epidermal growth factor receptor (EGFR). The US FDA approved necitumumab under the brand name Portrazza for use with gemcitabine and cisplatin in previously untreated metastatic squamous non-small-cell lung carcinoma (NSCLC). It was counterproductive in non-squamous non-small-cell lung carcinoma.
随便看	Inhibitors,GDP Dissociation Inhibitors,Growth Inhibitors,Guanine Nucleotide Dissociation Inhibitors,HIV Integrase Inhibitors,HIV Protease Inhibitors,HMG CoA Reductase Inhibitors,Hydroxymethylglutaryl CoA Inhibitors,Hydroxymethylglutaryl Coenzyme A Inhibitors,Integrase Inhibitors,Irreversible Cholinesterase Inhibitors,Kininase II Inhibitors,Lipoxygenase Inhibitors,MAO Inhibitors,Monoamine Oxidase Inhibitors,Neovascularization Inhibitors,Neurotransmitter Reuptake Inhibitors,Neurotransmitter Uptake Inhibitors,Nucleic Acid Synthesis inhibitors of collagenases inhibitors of drug metabolizing enzymes inhibitors of fibrinolysis inhibitors of metalloproteinase inhibitors of thromboplastin inhibitor solution inhibitors on the release of allergic mediators